Literature DB >> 2391513

Subcellular distribution of acetylcholinesterase in Alzheimer's disease: abnormal localization and solubilization.

S Nakamura1, S Kawashima, S Nakano, T Tsuji, W Araki.   

Abstract

AChE activity was detected mainly in membrane-bound fractions in the frontal cortex of autopsied control or Alzheimer brain as well as rat cerebral cortex. However, the distribution of AChE among various membrane fractions was different between control and Alzheimer brains. The highest specific activity was detected in the fraction enriched with senile plaque, which was obtained from the Alzheimer brain by sonication, solubilization with detergent and centrifugation on a sucrose density gradient. The senile plaque enriched fraction was incubated with purified collagenase or protease and centrifuged at 100,000 g for 60 min. More than 50% of AChE activity was detected in the supernatant fraction. AChE in the supernatant solution showed a property of G4 isozyme. AChE might probably be anchored to the senile plaque through its collagen tail and be solubilized with collagenase or protease, producing a G4 isozyme.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2391513     DOI: 10.1007/978-3-7091-3345-3_2

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  3 in total

1.  Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils.

Authors:  A Alvarez; R Alarcón; C Opazo; E O Campos; F J Muñoz; F H Calderón; F Dajas; M K Gentry; B P Doctor; F G De Mello; N C Inestrosa
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

2.  Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.

Authors:  M A Morán; E J Mufson; P Gómez-Ramos
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706.

Authors:  Francisco J Carvajal; Nibaldo C Inestrosa
Journal:  Front Mol Neurosci       Date:  2011-09-14       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.